Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Intra Cellular Therapies Inc | ITCI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 71.81 | 04:09:12 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 71.81 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 45.50 - 84.89 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 71.81 | USD |
Intra Cellular Therapies Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 6.95B | 96.81M | - | 464.37M | -139.67M | -1.44 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Intra Cellular Therapies News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ITCI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 73.74 | 74.12 | 71.35 | 72.49 | 676,597 | -1.93 | -2.62% |
| 1 Month | 66.28 | 84.89 | 64.155 | 74.03 | 1,408,078 | 5.53 | 8.34% |
| 3 Months | 70.20 | 84.89 | 62.78 | 71.75 | 984,030 | 1.61 | 2.29% |
| 6 Months | 50.01 | 84.89 | 49.30 | 67.48 | 925,065 | 21.80 | 43.59% |
| 1 Year | 62.66 | 84.89 | 45.50 | 63.29 | 827,223 | 9.15 | 14.60% |
| 3 Years | 34.71 | 84.89 | 28.40 | 54.11 | 771,339 | 37.10 | 106.89% |
| 5 Years | 13.22 | 84.89 | 6.75 | 38.50 | 944,127 | 58.59 | 443.19% |
Intra Cellular Therapies Description
| Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders. |
